Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 08, 2021 / 06:50PM GMT
Release Date Price: $238.5 (+8.69%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

Hello, and welcome to the 2021 Credit Suisse Healthcare Conference. I'm Judah Frommer, Senior Biotech Analyst here at Credit Suisse, and we're thrilled to have David Meline, CFO; and Lavina Talukdar, Head of IR, from Moderna with us.

With that, I think we can jump right into Q&A.

Questions & Answers

Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

If the audience does have questions that they'd like to ask, they can certainly send them over to me via e-mail, [email protected]. So first, maybe we could start out with a little bit of background. And in this same place about 12 months ago, you guys were a little bit away from in EUA. Since then, obviously, millions of people have received the Spikevax COVID -- the Spikevax COVID vaccine. The general pipeline has advanced, and there have been announcements regarding several research initiatives and manufacturing partnerships.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot